Herborium Group, Inc. Stock Other OTC
Equities
HBRM
US42703A2087
Biotechnology & Medical Research
Financials (USD)
Sales 2010 | 262K | Sales 2011 | 234K | Capitalization | 210K |
---|---|---|---|---|---|
Net income 2010 | - | Net income 2011 | - | EV / Sales 2010 | 10.7 x |
Net Debt 2010 | 588K | Net Debt 2011 | 621K | EV / Sales 2011 | 3.55 x |
P/E ratio 2010 |
-4.35
x | P/E ratio 2011 |
-0.97
x | Employees | - |
Yield 2010 * |
-
| Yield 2011 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 02-06-03 |
John Donahue
AUD | Comptroller/Controller/Auditor | 74 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 02-06-03 |
1st Jan change | Capi. | |
---|---|---|
-2.95% | 102B | |
+2.11% | 96.29B | |
+2.13% | 22.18B | |
-15.22% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.29% | 16.36B | |
+5.49% | 13.97B | |
+33.28% | 12.17B |